WallStreetZenWallStreetZen

NASDAQ: XENE
Xenon Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

XENE past revenue growth

How has XENE's revenue growth performed historically?
Company
-100%
Industry
148.4%
Market
16.96%
XENE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
XENE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

XENE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$182.4M
Current Profit Margin
0%

XENE Return on Equity

Current Company
-25.2%
Current Industry
-63.5%
Current Market
188%
XENE's Return on Equity (-25.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when XENE announces earnings.

XENE Return on Assets

Current Company
-24%
Current Industry
2.9%
XENE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

XENE Return on Capital Employed

Current Company
-19.49%
Current Industry
19.5%
XENE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XENE vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
XENE$0.00-$179.14M-$182.39M-100.00%N/A
IDYA$23.39M-$108.95M-$112.96M+58.18%N/A
CRNX$4.01M-$212.22M-$214.53M+10.57%N/A
IMCR$249.43M-$50.00M-$55.29M+53.19%N/A
ARWR$181.74M-$262.45M-$296.81M+30.90%N/A
View Top Biotech Stocks

XENE earnings dates

Next earnings date
May 7, 2024

Xenon Pharmaceuticals Earnings & Revenue FAQ

What were XENE's earnings last quarter?

On Invalid Date, Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 2023 earnings per share (EPS) of -$0.64, up 12.28% year over year. Total Xenon Pharmaceuticals earnings for the quarter were -$44.74 million. In the same quarter last year, Xenon Pharmaceuticals's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Xenon Pharmaceuticals stock.

What was XENE's earnings growth in the past year?

As of Q2 2024, Xenon Pharmaceuticals's earnings has grown year over year. Xenon Pharmaceuticals's earnings in the past year totalled -$182.39 million.

What is XENE's earnings date?

Xenon Pharmaceuticals's earnings date is Invalid Date. Add XENE to your watchlist to be reminded of XENE's next earnings announcement.

What was XENE's revenue last quarter?

On Invalid Date, Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Xenon Pharmaceuticals's revenue was $0.00.

What was XENE's revenue growth in the past year?

As of Q2 2024, Xenon Pharmaceuticals's revenue has grown -100% year over year. This is 248.4 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Xenon Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.